Droperidol, Ziprasidone or Ativan for Agitation Control in the ED

Martel ML, Driver BE, Miner JR, Biros MH, Cole JB. Randomized Double-blind Trial of Intramuscular Droperidol, Ziprasidone, and Lorazepam for Acute Undifferentiated Agitation in the Emergency Department. Acad Emerg Med. 2021 Apr;28(4):421-434. doi: 10.1111/acem.14124. Epub 2020 Oct 5. PMID: 32888340. The answer is still Droperidol however given the small sample size this still needs to […]

Pressure Support Or T-Piece Trials

There may not be much data on which type of Weaning trial is best..But if there were Id pick this one!

Prophylactic or Surveillance Splenic artery embolization

A Road Map for TEE

Ever Wondered where to start learning TEE? Well here is a roadmap to help understand the images. Look back soon for more learning! Download the pdf below:

Is there a DIF between H2 and PPI’s in the mechanically ventilated ICU patient

Only the A-E-I-O-U’s to start RRT and now we know “Y”! The Start-AKI Trial

In residency and med school we are always taught the indications for emergent CRRT as the mnemonic: AEIOU Acidosismetabolic acidosis with a pH < 7.1 Electrolytes hyperkalemia > 6.5 mEq/L refractory to treatment or rapidly rising levels in potassiumIngestionswith dialyzable drug, including salicylates, lithium, isopropanol, methanol, and ethylene glycol (SLIME)Overloadvolume overload that does not respond […]

I CAN Drive 65?…In Shock: A Trial of MAP 60-65 in Patients 65 years or older requiring vasopressors

Atrial fibrillation in the ICU: Tough AF to Treat, Sick AF to care for…

Peer Reviewed by Dr. Sagar Dave, DO Every once in a while, it’s a good thing to get down to the nitty gritty of things. I think this is most helpful in common situations. Atrial fibrillation is one of those things to have quickly accessible in your internal brain. In this episode I want to […]

Conservative vs Interventional Management of Spontaneous Primary Pneumothoracies (PSP)

COVID-19 RISK FACTORS: Who gets them and why. You are going to ACE this one…

Now usually I don’t go and make wild conjectures and hypotheses. But Im going to discuss a pretty interesting (wild conjecture?) one that on paper seems to make sense to me. Let’s look at the COVID-19 risk factors for who gets severe disease and put them in a molecular and biological framework. If you want you […]